logo
Sign in

RGEN Stock Price, Chart, Stats & News

Repligen Corporation
Save
7.81B
Market cap
76.95x
Current P/E
64.10x
Forward P/E

RGEN chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
50.91%
Operating margin
7.57%
Pretax margin
8.45%
Net margin
6.62%
Effective tax rate
21.62%
ROA
1.66%
ROE
2.37%
D/E
0.33x
Interest coverage ratio
1.25x

RGEN valuation

P/E
76.95x
P/S
8.40x
P/B
2.96x
P/CF
53.01x
P/FCF
67.91x
P/OCF
53.01x
PEG
0.05x
EV multiple
34.42x

About

Repligen Corporation specializes in the creation and distribution of advanced bioprocessing technologies and integrated systems. These solutions are vital for various stages of biological drug production, serving clients across North America, Europe, the Asia Pacific region, and other international markets. The company's diverse product portfolio includes crucial components for biomanufacturing.

Similar securities

Based on sector and market capitalization

Report issue